Zoetis Inc. (NYSE:ZTS) has been given a consensus rating of “Buy” by the seventeen analysts that are presently covering the stock, ARN reports. Five investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $35.73. Zoetis Inc. (NYSE:ZTS) stock opened at $29.56 in last session, and closed at $30.13, while the day range of Zoetis Inc. (NYSE:ZTS) stock is $29.55 – $30.38. The stock showed a positive weekly performance of -0.46%.
Mylan Inc. (NASDAQ:MYL) this week announced that its subsidiary Agila Specialties Private Limited is conducting a voluntary nationwide recall in the United States of the hospital/user-level certain lots of Etomidate Injection which is used for induction of general anaesthesia. Mylan Inc. (NASDAQ:MYL) stock opened at $51.00 in last session, and closed at $51.33 by gaining 0.55%. The 52 week range of $27.66 – $52.44. Company’s market capitalization is $19.61B.
Equities researchers at RBC Capital increased their price target on shares of Actavis plc Ordinary Shares (NYSE:ACT) from $240.00 to $249.00 in a research report issued on Friday, Analyst RN reports. The firm currently has an “outperform” rating on the stock. RBC Capital’s target price points to a potential upside of 11.98% from the company’s current price. Actavis plc (NYSE:ACT) stock increased 1.18% and finished the last session at $225.00. The EPS of the stock remained -4.36. Company’s market capitalization is $29.81B.
Myrexis Inc. (OTCMKTS: MYRX) is a biopharmaceutical company that has generated a pipeline of differentiated drug candidates in oncology and autoimmune diseases. The Company retains all rights to all of its drug candidates and programs across all geographic markets and therapeutic indications. Myrexis Inc. (OTCMKTS: MYRX) stock opened the session at $0.19, and closed the session at $0.160. The 52 week range of the Myrexis Inc. (OTCMKTS: MYRX) stock remained $0.06 – $0.24 and the day range was $0.16 – $0.19.
Leave a Reply